Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Cuorips Inc.. A complete text table follows the diagram.
A cardiac cell sheet leads the pipeline, while U.S. development, catheter delivery and CDMO capacity widen the route from laboratory to treatment.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| iPS cardiac, regenerative & CDMO platform | 1 | 193M | 100.0% of reported total |
| Revenue | 2 | 193M | JPY193M interim sales |
| From | To | Value |
|---|---|---|
| iPS cardiac, regenerative & CDMO platform | Revenue | 193M |